Diagnosis of Circulatory Encephalopathy and Biophilia Intruder

Diagnosis of Circulatory Encephalopathy and Biophilia Intruder

More recently, chronic forms of cerebrovascular disease have become more important in the structure of cerebrovascular disease. Among them, circulatory disorder encephalopathy (DE) has the largest proportion. The clinical manifestations of the disease are well studied, but at the same time, from a case medicine perspective, the detection of structural changes in the brain, the identification of clinical and instrumental similarities, and the early definition of optimal strategies for treatment have become increasingly more urgent.

We can diagnose DE using an Indruter system with a generator frequency of 4.9 GHz and the Biophilia Intruder software.

The clinical manifestations of DE are progressive. The analysis of the NLS-study findings confirmed that in the first stage of the disease, there are no characteristic changes in the brain and no overt neurological syndrome develops; subjective impairment, with mild neurosemiotics, predominates. The second stage of DE allowed us to single out certain prevalent neurological syndromes - incoordination, pyramidal and dystonia, presenting as single or multiple gliomas with no tendency to merge, which is a patient specialty and social adaptation for significant reductions. According to the data obtained by NLS-research with REA, in the third stage of DE, the number of chief complaints decreases significantly, but neurological disorders become more pronounced, they present in the form of very distinct and prominent neurological syndromes, combined with Significant changes in brain structure.

Consequently, as DE progresses, structural changes in brain tissue become more frequent: the frequency and extent of atrophy, a single cystic nest of changes in the brain becomes multiple.

The diagnosis of DE should be complex, including methods of neural visualization, of which we believe one of the most informative and prospective methods is NLS imaging with REA. Detection and assessment of nested and diffuse NLS changes in brain tissue in the context of clinical and subclinical neurological and neuropsychological data for early diagnosis of progressive forms of DE and targeted aggressive treatment to prevent further brain injury creating condition.